Biodesix to report third quarter 2023 financial results on november 7, 2023

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for the third quarter ended september 30, 2023 after the close of trading on tuesday, november 7. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. eastern time on the same day. listeners can register for the webcas.
BDSX Ratings Summary
BDSX Quant Ranking